Freeing the world of musculoskeletal pain

As a proudly Swiss company, we’re committed to proven products and guiding our partners with wise counsel

Management Team

Leading our Aptissen team with her characteristic passion and delivering our mission to free the musculoskeletal world of pain.

Carole Scheibli

CEO

Committed to reliable and flexible financial management in a dynamic environment.

Nicolas Marsault

VP Finance

Driving the messaging and positioning of our portfolio in our everchanging modern society towards our healthcare practitioners and consumers alike. Sales growth is the result of consistency and true collaboration with our global network.

Silvia Scherer

VP Sales & Marketing

Fostering a culture of medical and scientific rigor and ethical behavior and representing the voice of the patient, ensuring that it is at the forefront of all our decisions.

Eduard Vidovic

VP Medical Affairs

Optimizing and maintaining our high standards globally across all processes and stakeholders from sourcing to delivery of our solutions.

Alban Arsene

VP Operations

Our history

Founded in 2013, we have come a long way in a short period of time

01
2009

Launch of
SynolisTM VA 40/80

02
2009

European patent on crossover frequency and concentration

03
2013

Spin off Anteis - Aptissen Creation

04
2015

Subsidiary in Italy

05
2018

ISO 13485:2016

06
2018

Subsidiary in Poland

07
2019

Launch of SynolisTM VA 80/160 – CE mark

08
2019

Subsidiary in France

09
2020

MDSAP (Canada – Brazil)

10
2020

2020 Launch of Cartylis TM

Quality

Quality is paramount as we are dedicated to the well-being of each and every person benefiting from our products.